182 related articles for article (PubMed ID: 158524)
1. Kinetics of the reactions between streptokinase, plasmin and alpha 2-antiplasmin.
Cederholm-Williams SA; De Cock F; Lijnen HR; Collen D
Eur J Biochem; 1979 Oct; 100(1):125-32. PubMed ID: 158524
[TBL] [Abstract][Full Text] [Related]
2. [Effect of streptokinase on the interaction of alpha-2-antiplasmin with different sites of plasmin molecule].
Iusova EI; Grinenko TV; Volkov GL
Ukr Biokhim Zh (1999); 2004; 76(2):98-106. PubMed ID: 15915719
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasmin, miniplasmin, and streptokinase-plasmin complex by alpha 2-antiplasmin, alpha 2-macroglobulin, and antithrombin III in the presence of heparin.
Anonick PK; Wolf B; Gonias SL
Thromb Res; 1990 Aug; 59(3):449-62. PubMed ID: 1700488
[TBL] [Abstract][Full Text] [Related]
5. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
Silence K; Collen D; Lijnen HR
J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
[TBL] [Abstract][Full Text] [Related]
6. Influence of soluble fibrin on reaction kinetics of plasmin type 1 and type 2 with alpha2-antiplasmin.
Ries M; Zenker M
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):203-9. PubMed ID: 12632033
[TBL] [Abstract][Full Text] [Related]
7. On the kinetics of the reaction between human antiplasmin and a low-molecular-weight form of plasmin.
Wiman B; Boman L; Collen D
Eur J Biochem; 1978 Jun; 87(1):143-6. PubMed ID: 149657
[TBL] [Abstract][Full Text] [Related]
8. On the reaction of plasmin or plasmin-streptokinase complex with aprotinin or alpha 2-antiplasmin.
Wiman B
Thromb Res; 1980 Jan 1-15; 17(1-2):143-52. PubMed ID: 6154981
[No Abstract] [Full Text] [Related]
9. Structural domains of streptokinase involved in the interaction with plasminogen.
Rodríguez P; Fuentes P; Barro M; Alvarez JG; Muñoz E; Collen D; Lijnen HR
Eur J Biochem; 1995 Apr; 229(1):83-90. PubMed ID: 7744053
[TBL] [Abstract][Full Text] [Related]
10. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
[TBL] [Abstract][Full Text] [Related]
11. Reaction of human alpha2-antiplasmin and plasmin stopped-flow fluorescence kinetics.
Christensen U; Bangert K; Thorsen S
FEBS Lett; 1996 May; 387(1):58-62. PubMed ID: 8654567
[TBL] [Abstract][Full Text] [Related]
12. [Kinetics of in vitro fibrinolysis by plasmin and a plasmin-streptokinase equimolar complex].
Aĭsina RB; Zhitkova IuV; Eremeev NL; Popova GIu; Kazanskaia NF
Ukr Biokhim Zh (1978); 1991; 63(1):20-6. PubMed ID: 1827551
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytic activities of alpha-N-acetyl-L-lysine methyl ester, epsilon-aminocaproic acid, and tranexamic acid. Importance of kringle interactions and active site inhibition.
Anonick PK; Vasudevan J; Gonias SL
Arterioscler Thromb; 1992 Jun; 12(6):708-16. PubMed ID: 1375508
[TBL] [Abstract][Full Text] [Related]
14. Serpin-serine protease binding kinetics: alpha 2-antiplasmin as a model inhibitor.
Longstaff C; Gaffney PJ
Biochemistry; 1991 Jan; 30(4):979-86. PubMed ID: 1703440
[TBL] [Abstract][Full Text] [Related]
15. Catabolic pathways for streptokinase, plasmin, and streptokinase activator complex in mice. In vivo reaction of plasminogen activator with alpha 2-macroglobulin.
Gonias SL; Einarsson M; Pizzo SV
J Clin Invest; 1982 Aug; 70(2):412-23. PubMed ID: 6178757
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) promotes plasmin inhibition by alpha 2-antiplasmin.
Edelberg JM; Pizzo SV
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):79-84. PubMed ID: 1381585
[TBL] [Abstract][Full Text] [Related]
17. Chimerism reveals a role for the streptokinase Beta -domain in nonproteolytic active site formation, substrate, and inhibitor interactions.
Gladysheva IP; Sazonova IY; Chowdhry SA; Liu L; Turner RB; Reed GL
J Biol Chem; 2002 Jul; 277(30):26846-51. PubMed ID: 12016220
[TBL] [Abstract][Full Text] [Related]
18. alpha Domain deletion converts streptokinase into a fibrin-dependent plasminogen activator through mechanisms akin to staphylokinase and tissue plasminogen activator.
Sazonova IY; Robinson BR; Gladysheva IP; Castellino FJ; Reed GL
J Biol Chem; 2004 Jun; 279(24):24994-5001. PubMed ID: 15069059
[TBL] [Abstract][Full Text] [Related]
19. Activated thrombin-activatable fibrinolysis inhibitor reduces the ability of high molecular weight fibrin degradation products to protect plasmin from antiplasmin.
Schneider M; Brufatto N; Neill E; Nesheim M
J Biol Chem; 2004 Apr; 279(14):13340-5. PubMed ID: 14715654
[TBL] [Abstract][Full Text] [Related]
20. Interaction of SK-human plasmin, SK-dog plasmin complexes with alpha 2-antiplasmin and alpha 2-macroglobulin.
Reddy KN; Cercek B; Lew AS; Ganz W
Thromb Res; 1986 Mar; 41(5):671-80. PubMed ID: 2421434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
